| |
LGV negative
|
LGV positive
|
P value
|
|---|
| |
N = 95
|
N = 13
| |
|---|
|
Reported symptoms % (n)
|
20% (19)
|
100% (13)
|
<0.001
|
|
MSM %
(n)
|
91.6% (87)
|
100% (13)
|
0.601
|
|
Mean age (±SD), (range)
|
34 years (±9.5), (18–64)
|
43 years (±6.3), (27–53)
|
0.0008
|
|
Mean anti-Chlamydia IgG AU/ml, (range)
£
|
11.8 (4–38)
|
60.4 (19–86)
|
<0.001
|
|
Presence of coinfections
†
% (n)
|
47.3% (45)
|
92.3% (12)
|
0.0023
|
|
HIV % (n)
|
10.5% (10)
|
69.2% (9)
|
<0.001
|
|
Syphilis % (n)
|
16.8% (16)
|
69.2% (9)
|
<0.001
|
|
Gonorrhoea* % (n)
|
17.8% (17)
|
23.0% (3)
|
0.6519
|
|
Non-L serovar CT* % (n)
|
13.7% (13)
|
0% (0)
|
0.155
|
|
HBV % (n)
|
3.2% (3)
|
30.8% (4)
|
0.001
|
|
HCV % (n)
|
1.1% (1)
|
7.7% (1)
|
0.570
|
|
HPV warts % (n)
|
10.5% (10)
|
30.8% (4)
|
0.110
|
- † A patient was considered coinfected when at least one of the following infections was present: HIV, gonorrhoea, non-L CT, HBV, HCV, HPV warts.
- *A patient was considered gonorrhoea or non-L CT positive when at least one of the site tested (pharyngeal swab and/or rectal swab and/or urine) resulted positive.
- £ Normal values: IgG <15 Arbitrary Units/ml.
